Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Mekondjo! National exhibition to reveal the courage, determination, repression and torture of PLAN
2014-05-21

 
Angelina Angula ex PLAN soldier injured during the 1978 Cassinga attack - photo by John Liebenberg.

A pioneering exhibition by John Liebenberg and Christo Doherty is about to open on the Bloemfontein Campus. ‘Mekondjo! born in the struggle for Namibia’ gives South Africans their first insight into the lives of the men and women who fought against the SADF in the bush of Northern Namibia and Angola from 1966 – 1989.

This public exhibition presents eleven portraits of People’s Liberation Army veterans in the process of speaking about and coming to terms with their very different experiences in the Namibian War of Liberation.

When the People’s Liberation Army (PLAN) returned to Namibia after the UN-supervised elections of 1989, it had been fighting against South African rule for 23 years. Formed in 1966 as the armed wing of the South West African Peoples’ Organisation, PLAN had developed from a handful of poorly armed guerrillas to a sophisticated mechanised force. These soldiers fought alongside Angolan, Russian and Cuban soldiers against the SADF and UNITA. Since SWAPO’s election victory, the new government has mythologised the heroism of the armed struggle. The stories of the individual PLAN fighters’ experiences are only now being articulated, though.

Their stories are of great courage and determination against often impossible odds; but also of repression, torture, and disastrous decisions by the PLAN leadership.

The exhibition will be on display from Thursday 22 May to Friday 23 May for the duration of the Silence after Violence conference. The conference is hosted by the UFS Institute for Reconciliation and Social Justice and the Center for Holocaust Studies at the University of Vermont.

Date: Thursday 22 May and Friday 23 May 2014
Place: Centenary Complex, Reitz Hall, Bloemfontein Campus
Exhibition Introduction: Thursday 22 May, 14:00 – 15:30
Other viewing times: intermissions during the Silence after Violence programme

The public is welcome to attend.

* Spotlight photo: PLAN commissioner Nkrumah Mushelenga, Windhoek 2013 – photo by John Liebenberg

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept